Guardion Total Current Assets vs Total Liab Analysis

GHSI Stock

USD 9.53 0.28 3.03%

Guardion Health financial indicator trend analysis is much more than just examining Guardion Health Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Guardion Health Sciences is a good investment. Please check the relationship between Guardion Health Total Current Assets and its Total Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardion Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Total Current Assets vs Total Liab

Total Current Assets vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Guardion Health Sciences Total Current Assets account and Total Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Guardion Health's Total Current Assets and Total Liab is 0.63. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Total Liab in the same time period over historical financial statements of Guardion Health Sciences, assuming nothing else is changed. The correlation between historical values of Guardion Health's Total Current Assets and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Guardion Health Sciences are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Total Current Assets i.e., Guardion Health's Total Current Assets and Total Liab go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Guardion Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Guardion Health Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardion Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

The current Selling General Administrative is estimated to decrease to about 6.8 M. The current Issuance Of Capital Stock is estimated to decrease to about 4.1 M

Guardion Health fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Inventory	Other Stockholder Equity	Total Liab	Total Current Assets	Property Plant Equipment	Short Long Term Debt Total	Other Current Liab	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total
Total Assets		0.32	-0.14	0.92	0.69	-0.58	0.44	0.6	0.94	0.44	0.94	0.05	-0.7	0.58	0.97	0.9	0.1	-0.81	-0.87	0.53	0.79	0.56	-0.58	0.02	0.57	0.49
Total Current Liabilities	0.32		-0.25	0.2	0.43	0.27	-0.1	0.54	0.25	0.94	0.47	-0.36	-0.1	0.91	0.11	0.01	-0.37	-0.21	-0.34	0.79	0.22	-0.19	0.04	-0.43	-0.05	0.78
Other Assets	-0.14	-0.25		-0.22	-0.17	-0.16	-0.02	-0.1	-0.05	-0.22	-0.2	0.03	0.16	-0.2	-0.1	-0.16	0.04	0.19	0.08	-0.02	-0.21	0.11	0.11	-0.09	-0.08	-0.2
Cash And Short Term Investments	0.92	0.2	-0.22		0.55	-0.61	0.44	0.54	0.87	0.35	0.94	0.37	-0.6	0.39	0.9	0.97	0.41	-0.96	-0.79	0.47	0.96	0.34	-0.34	0.28	0.33	0.44
Net Receivables	0.69	0.43	-0.17	0.55		-0.37	0.76	0.92	0.78	0.58	0.71	-0.42	-0.73	0.63	0.61	0.58	-0.4	-0.56	-0.92	0.58	0.5	0.16	-0.27	-0.32	0.25	0.79
Common Stock Shares Outstanding	-0.58	0.27	-0.16	-0.61	-0.37		-0.62	-0.37	-0.68	0.04	-0.56	-0.12	0.69	-0.07	-0.62	-0.66	-0.19	0.63	0.58	-0.3	-0.59	-0.29	0.19	-0.16	-0.18	-0.16
Long Term Debt Total	0.44	-0.1	-0.02	0.44	0.76	-0.62		0.72	0.69	0.18	0.5	-0.18	-0.68	0.13	0.43	0.57	-0.15	-0.52	-0.75	0.3	0.47	0.0	-0.01	-0.09	0.0	0.47
Inventory	0.6	0.54	-0.1	0.54	0.92	-0.37	0.72		0.72	0.73	0.73	-0.33	-0.65	0.68	0.46	0.51	-0.31	-0.65	-0.87	0.77	0.59	-0.15	0.07	-0.26	-0.08	0.93
Other Stockholder Equity	0.94	0.25	-0.05	0.87	0.78	-0.68	0.69	0.72		0.44	0.92	0.0	-0.77	0.52	0.9	0.9	0.04	-0.81	-0.95	0.58	0.78	0.43	-0.45	-0.08	0.43	0.55
Total Liab	0.44	0.94	-0.22	0.35	0.58	0.04	0.18	0.73	0.44		0.63	-0.33	-0.27	0.93	0.22	0.19	-0.33	-0.41	-0.52	0.88	0.41	-0.25	0.12	-0.33	-0.13	0.91
Total Current Assets	0.94	0.47	-0.2	0.94	0.71	-0.56	0.5	0.73	0.92	0.63		0.1	-0.67	0.66	0.85	0.87	0.14	-0.91	-0.88	0.71	0.91	0.25	-0.28	0.07	0.27	0.69
Property Plant Equipment	0.05	-0.36	0.03	0.37	-0.42	-0.12	-0.18	-0.33	0.0	-0.33	0.1		0.35	-0.45	0.14	0.35	1.0	-0.36	0.12	-0.27	0.43	-0.05	0.12	0.66	-0.12	-0.34
Short Long Term Debt Total	-0.7	-0.1	0.16	-0.6	-0.73	0.69	-0.68	-0.65	-0.77	-0.27	-0.67	0.35		-0.4	-0.68	-0.64	0.3	0.61	0.77	-0.49	-0.54	-0.32	0.32	0.13	-0.31	-0.45
Other Current Liab	0.58	0.91	-0.2	0.39	0.63	-0.07	0.13	0.68	0.52	0.93	0.66	-0.45	-0.4		0.39	0.24	-0.44	-0.37	-0.57	0.83	0.36	0.06	-0.18	-0.37	0.17	0.83
Total Stockholder Equity	0.97	0.11	-0.1	0.9	0.61	-0.62	0.43	0.46	0.9	0.22	0.85	0.14	-0.68	0.39		0.92	0.18	-0.77	-0.81	0.34	0.75	0.68	-0.67	0.11	0.66	0.3
Net Tangible Assets	0.9	0.01	-0.16	0.97	0.58	-0.66	0.57	0.51	0.9	0.19	0.87	0.35	-0.64	0.24	0.92		0.39	-0.91	-0.81	0.32	0.9	0.43	-0.41	0.29	0.4	0.33
Property Plant And Equipment Net	0.1	-0.37	0.04	0.41	-0.4	-0.19	-0.15	-0.31	0.04	-0.33	0.14	1.0	0.3	-0.44	0.18	0.39		-0.4	0.09	-0.24	0.46	-0.02	0.1	0.66	-0.1	-0.33
Net Debt	-0.81	-0.21	0.19	-0.96	-0.56	0.63	-0.52	-0.65	-0.81	-0.41	-0.91	-0.36	0.61	-0.37	-0.77	-0.91	-0.4		0.79	-0.56	-0.99	-0.08	0.07	-0.31	-0.05	-0.55
Retained Earnings	-0.87	-0.34	0.08	-0.79	-0.92	0.58	-0.75	-0.87	-0.95	-0.52	-0.88	0.12	0.77	-0.57	-0.81	-0.81	0.09	0.79		-0.63	-0.74	-0.28	0.33	0.19	-0.32	-0.71
Accounts Payable	0.53	0.79	-0.02	0.47	0.58	-0.3	0.3	0.77	0.58	0.88	0.71	-0.27	-0.49	0.83	0.34	0.32	-0.24	-0.56	-0.63		0.54	-0.19	0.15	-0.38	-0.16	0.86
Cash	0.79	0.22	-0.21	0.96	0.5	-0.59	0.47	0.59	0.78	0.41	0.91	0.43	-0.54	0.36	0.75	0.9	0.46	-0.99	-0.74	0.54		0.06	-0.05	0.35	0.04	0.53
Non Current Assets Total	0.56	-0.19	0.11	0.34	0.16	-0.29	0.0	-0.15	0.43	-0.25	0.25	-0.05	-0.32	0.06	0.68	0.43	-0.02	-0.08	-0.28	-0.19	0.06		-0.95	-0.07	0.96	-0.3
Non Currrent Assets Other	-0.58	0.04	0.11	-0.34	-0.27	0.19	-0.01	0.07	-0.45	0.12	-0.28	0.12	0.32	-0.18	-0.67	-0.41	0.1	0.07	0.33	0.15	-0.05	-0.95		0.18	-1.0	0.18
Common Stock Total Equity	0.02	-0.43	-0.09	0.28	-0.32	-0.16	-0.09	-0.26	-0.08	-0.33	0.07	0.66	0.13	-0.37	0.11	0.29	0.66	-0.31	0.19	-0.38	0.35	-0.07	0.18		-0.18	-0.27
Short Term Investments	0.57	-0.05	-0.08	0.33	0.25	-0.18	0.0	-0.08	0.43	-0.13	0.27	-0.12	-0.31	0.17	0.66	0.4	-0.1	-0.05	-0.32	-0.16	0.04	0.96	-1.0	-0.18		-0.19
Non Current Liabilities Total	0.49	0.78	-0.2	0.44	0.79	-0.16	0.47	0.93	0.55	0.91	0.69	-0.34	-0.45	0.83	0.3	0.33	-0.33	-0.55	-0.71	0.86	0.53	-0.3	0.18	-0.27	-0.19

Click cells to compare fundamentals

Guardion Health Account Relationship Matchups

Guardion Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	12.9M	9.9M	23.5M	21.7M	11.9M	10.1M
Total Current Liabilities	410.2K	1.1M	1.2M	4.0M	1.3M	1.3M
Cash And Short Term Investments	11.1M	8.5M	9.1M	10.7M	6.4M	5.6M
Net Receivables	78.3K	11.2K	1.4M	1.9M	2.3M	2.4M
Common Stock Shares Outstanding	121.6K	47.5K	473.8K	1.1M	1.3M	1.5M
Inventory	310.9K	385.0K	367.7K	3.1M	2.7M	2.8M
Other Stockholder Equity	57.5M	62.6M	101.1M	101.6M	101.7M	58.7M
Total Liab	845.0K	1.3M	1.2M	8.5M	3.8M	2.3M
Total Current Assets	11.9M	9.1M	12.1M	21.6M	11.9M	8.0M
Property Plant Equipment	947.4K	704.3K	135.6K	48.9K	56.2K	53.4K
Other Current Liab	13.3K	26.0K	895.5K	2.5M	704.9K	608.5K
Total Stockholder Equity	12.0M	8.5M	22.3M	13.2M	8.1M	8.9M
Net Tangible Assets	12.0M	8.5M	11.0M	7.9M	9.1M	6.0M
Property Plant And Equipment Net	947.4K	704.3K	135.6K	48.9K	33.2K	31.6K
Net Debt	(10.5M)	(8.1M)	(4.1M)	(10.7M)	(6.4M)	(6.7M)
Retained Earnings	(45.5M)	(54.1M)	(78.8M)	(93.7M)	(93.6M)	(88.9M)
Accounts Payable	129.1K	608.3K	241.3K	1.5M	614.1K	545.7K
Cash	11.1M	8.5M	4.1M	10.7M	6.4M	5.6M
Non Current Assets Total	1.0M	766.0K	11.4M	48.9K	33.2K	31.6K
Common Stock Total Equity	40.2K	20.6K	75.0K	15.2K	17.4K	16.6K
Liabilities And Stockholders Equity	12.9M	9.9M	23.5M	21.7M	11.9M	11.2M
Non Current Liabilities Total	434.7K	271.9K	3.8K	4.5M	2.5M	2.6M
Capital Surpluse	33.7M	37.8M	57.5M	62.6M	72.0M	41.2M
Other Current Assets	362.9K	179.9K	1.2M	687.9K	573.8K	393.3K
Property Plant And Equipment Gross	947.4K	704.3K	272.0K	176.1K	179.9K	358.7K
Accumulated Other Comprehensive Income	(309.4K)	(380.6K)	0.0	(11.9M)	(10.7M)	(10.2M)
Short Term Debt	151.6K	162.8K	22.2K	3.8K	3.4K	3.3K
Intangible Assets	620.7K	456.1K	50K	11.3M	12.9M	13.6M
Common Stock	75.0K	15.2K	24.4K	1.3K	1.3K	1.2K
Net Invested Capital	12.0M	8.5M	22.3M	7.9M	8.1M	10.8M
Net Working Capital	11.5M	8.0M	10.9M	17.6M	10.6M	10.0M
Capital Stock	75.0K	15.2K	24.4K	5.3M	1.3K	1.2K

Currently Active Assets on Macroaxis

V	Visa Class A
BAC	Bank of America
GM	General Motors
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Guardion Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardion Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardion Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardion Health Sciences Stock:

How To Invest In Guardion

Details

Is Guardion Stock a good investment?

Details

What is Guardion Health's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Drug Manufacturers - Specialty & Generic Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardion Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Guardion Stock analysis

When running Guardion Health's price analysis, check to measure Guardion Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardion Health is operating at the current time. Most of Guardion Health's value examination focuses on studying past and present price action to predict the probability of Guardion Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardion Health's price. Additionally, you may evaluate how the addition of Guardion Health to your portfolios can decrease your overall portfolio volatility.

	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes

Is Guardion Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardion Health. If investors know Guardion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardion Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.01)

Revenue Per Share

9.468

Quarterly Revenue Growth

(0.06)

Return On Assets

(0.18)

Return On Equity

(0.86)

The market value of Guardion Health Sciences is measured differently than its book value, which is the value of Guardion that is recorded on the company's balance sheet. Investors also form their own opinion of Guardion Health's value that differs from its market value or its book value, called intrinsic value, which is Guardion Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardion Health's market value can be influenced by many factors that don't directly affect Guardion Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Guardion Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardion Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardion Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guardion Total Current Assets vs Total Liab Analysis

Total Current Assets vs Total Liab

Total Current Assets vs Total Liab Correlation Analysis

Correlation Coefficient

Total Current Assets

Total Liab

Guardion Health fundamental ratios Correlations

Guardion Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Guardion Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Guardion Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Property Plant Equipment
Total Stockholder Equity	+ 0.97	Total Assets
Net Tangible Assets	+ 0.97	Cash And Short Term Investments
Cash	+ 0.96	Cash And Short Term Investments
Short Term Investments	+ 0.96	Non Current Assets Total
Other Stockholder Equity	+ 0.94	Total Assets

Short Term Investments	- 1.0	Non Currrent Assets Other
Cash	- 0.99	Net Debt
Net Debt	- 0.96	Cash And Short Term Investments
Non Currrent Assets Other	- 0.95	Non Current Assets Total
Retained Earnings	- 0.95	Other Stockholder Equity
Retained Earnings	- 0.92	Net Receivables